Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01913197 · ClinicalTrials.gov registry record · Phase 1
Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy
A Phase 1 study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01913197: Clinical Trial Phase 1 study, sponsored by St. Luke's-Roosevelt Hospital Center.
NCT01913197 is a Phase 1 study that was terminated before completion, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 2 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01913197, a Phase 1 study, was terminated before completion, sponsored by St. Luke's-Roosevelt Hospital Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
In standard prostate brachytherapy treatment, the seeds are placed throughout the prostate to treat the entire gland. This is done because, in the past, it was impossible to know where the cancer was located within the prostate. Multiparametric magnetic resonance imaging (MRI) can identify tumor(s) with a high degree of accuracy. This trial will assess whether using MRI to guide prostate brachytherapy can result in less chronic toxicity by allowing lower doses to be delivered to the regions of the prostate without tumor while simultaneously allowing higher doses to the tumor. Subjects enrolled in this study will then be followed over two years and evaluated for toxicity. In addition, after two years they will undergo an MRI and a biopsy to assess the cancer control rate of the treatment.
Interventions
- OTHER An MRI-based technique to identify prostate cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-11 |
| Phase | Phase 1 |
Why NCT01913197 stopped before completion
NCT01913197 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which An MRI-based technique to identify prostate cancer is the first listed.
NCT01913197 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01913197 about?
NCT01913197 is a clinical study titled "Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy". In standard prostate brachytherapy treatment, the seeds are placed throughout the prostate to treat the entire gland. This is done because, in the past, it was impossible to know where the cancer was located within the prostate. Multiparametric magnetic resonance imaging (MRI) can identify tumor(s) ...
What is the current status of trial NCT01913197?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2013-08. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01913197?
The interventions under investigation include: An MRI-based technique to identify prostate cancer (OTHER).
Who is sponsoring clinical trial NCT01913197?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01913197's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia